| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 18 | / | 2023 | ||||||||
| Date of issue: | 2023-04-14 | ||||||||||
| Short name of the issuer | |||||||||||
| KRKA | |||||||||||
| Subject | |||||||||||
| Notification of transactions by persons discharging managerial responsibilities | |||||||||||
| Official market - legal basis | |||||||||||
| art. 17. 1 MAR. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Based on the provisions of the Rules of the Ljubljana Stock Exchange and Article 19 of Regulation (EU) No 596/2014, Krka, d. d., Novo mesto announces: The Deputy President of the Supervisory Board of Krka, d. d., Novo mesto, Franc Šašek, informed the company that on 13 April 2023 he disposed 900 shares of the company with the symbol KRKG (ISIN: SI0031102120) for his own account on the official market of the Ljubljana Stock Exchange at the price of EUR 109.00 per share. The transactions are not linked to the exercise of a share option programme. The notice will be published on the company's website (www.krka.biz) from 14 April 2023 onwards, for a period of at least 5 years. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| KRKA, TOVARNA ZDRAVIL D.D. | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| KRKA | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 8501 | Nove Mesto | ||||||||||||
| (post code) | (city) | ||||||||||||
| Smarjeska | 6 | ||||||||||||
| (street) | (number) | ||||||||||||
| +386 7 331 21 11 | +386 7 332 15 37 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nie dotyczy | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2023-04-14 | Jože Colarič | President of the Management Board and CEO | |||
